Article Data

  • Views 1311
  • Dowloads 115

Original Research

Open Access

Histopathologic correlation of dilatation & currettage and hysterectomy specimens in patients with postmenopausal bleeding

  • H. Saygili1,*,

1Department of Obstetrics and Gynecology, School of Medicine, Istanbul University, Istanbul, Turkey

DOI: 10.12892/ejgo200602182 Vol.27,Issue 2,March 2006 pp.182-184

Published: 10 March 2006

*Corresponding Author(s): H. Saygili E-mail:

Abstract

Purpose of investigation: To evaluate the consistency of preoperative and postoperative histopathological findings in postmenopausal patients with abnormal bleeding.

Methods: Pathologic diagnoses of 42 postmenopausal women with abnormal bleeding or increased endometrial thickness who underwent both dilatation and curettage (D and C), and hysterectomy for proper indications were retrospectively examined.

Results: The most common diagnosis was irregular proliferative endometrium in both the pre- and postoperative groups with 16 patients each (38%). After subgroup analysis, 50% of the patients with a preoperative diagnosis of complex hyperplasia without atypia, had complex atypical hyperplasia, and two-thirds of the patients with a preoperative diagnosis of complex atypical hyperplasia had endometrial cancer as the final diagnoses.

Conclusion: Preoperative D and C endometrial pathology findings positively correlated with postoperative hysterectomy pathology results. However, as the real pathology gets worse , D and C seems to under-diagnose the real pathology. In cases with complex hyperplasia with or without atypia , a second D and C or hysteroscopic evaluation may be recommended.

Keywords

Histopathogical correlation; Dilatation and curettage; Hysterectomy

Cite and Share

H. Saygili. Histopathologic correlation of dilatation & currettage and hysterectomy specimens in patients with postmenopausal bleeding. European Journal of Gynaecological Oncology. 2006. 27(2);182-184.

References

[1] Gordon M.D., Ireland K.: "Pathology of hyperplasia and carcinoma of the endometrium". Semin. Oneal., 1994, 21, 64.

[2] MacMahon B.: "Risk factors for endometrial cancer". Gynecol. Oneal., 1974, 2, 122.

[3] Hunter J.E., Tritz D.E., Howell M.G. et al.: "The prognostic and therapeutic implications of cytologic atypia in patients with endometrial hyperplasia". Gynecol. Oneal., 1994, 55, 63.

[4] Randall T.C., Kurman R.J.: "Progestin treatment of atypical hyperplasia and well differentiated carcinoma of the endometrium in women under age 40". Obstet. Gynecol., 1997, 90, 434.

[5] Chambers J.T., Chambers S.K.: "Endometrial sampling: When? Where? Why? With what?". Clin. Obstet. Gynecol., 1992, 35, 28.

[6] Kurman R.J., Kaminski P.F., Norris H.J.: "The behaviour of endometrial hyperplasia: A long term study of untreated 170 patients". Cancer, 1985, 56, 403.

[7] Grimes D.A.: "Diagnostic dilation and curettage: A reappraisal". Am. J. Obstet. Gynecol., 1982, 142, 1.

[8] Kaunitz A.M., Masciello A., Ostrowski M. et al.: "Comparison of endometrial biopsy with endometrial carcinoma and hyperplasia: a metaanalysis". Cancer, 2000, 89, 1765.

[9] Stelmachow J.: "The role of hysterescopy in gynecologic oncology". Gynecol. Oncol., 1982, 14, 392.

[10] Stock R.J., Kanbour A.: "Prehysterectomy curettage: an evaluation". Obstet. Gjnecol., 1975, 45, 537.

[11] Gundem G., Sedag F., Kazandi M. et al.: "Preoperative and postoperative correlation of histopathological findings in cases of endometrial hyperplasia". Eur. J. Gynaecol. Oncol., 2003, 24, 330.

Submission Turnaround Time

Top